| Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949, 2020 | 6588 | 2020 |
| Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry P Seng, M Drancourt, F Gouriet, B La Scola, PE Fournier, JM Rolain, ... Clinical infectious diseases 49 (4), 543-551, 2009 | 2220 | 2009 |
| Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria AO Olaitan, S Morand, JM Rolain Frontiers in microbiology 5, 643, 2014 | 1443 | 2014 |
| New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? CA Devaux, JM Rolain, P Colson, D Raoult International journal of antimicrobial agents 55 (5), 105938, 2020 | 1370 | 2020 |
| ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes SK Gupta, BR Padmanabhan, SM Diene, R Lopez-Rojas, M Kempf, ... Antimicrobial agents and chemotherapy 58 (1), 212-220, 2014 | 1313 | 2014 |
| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1305 | 2015 |
| Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult International journal of antimicrobial agents 55 (4), 105932, 2020 | 1187 | 2020 |
| Culture of previously uncultured members of the human gut microbiota by culturomics JC Lagier, S Khelaifia, MT Alou, S Ndongo, N Dione, P Hugon, A Caputo, ... Nature microbiology 1 (12), 2016 | 938 | 2016 |
| Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ... Travel medicine and infectious disease 34, 101663, 2020 | 924 | 2020 |
| Culturing the human microbiota and culturomics JC Lagier, G Dubourg, M Million, F Cadoret, M Bilen, F Fenollar, ... Nature Reviews Microbiology 16 (9), 540-550, 2018 | 729 | 2018 |
| Colistin: an update on the antibiotic of the 21st century S Biswas, JM Brunel, JC Dubus, M Reynaud-Gaubert, JM Rolain Expert review of anti-infective therapy 10 (8), 917-934, 2012 | 668 | 2012 |
| Recommendations for Treatment of Human Infections Caused by Bartonella Species JM Rolain, P Brouqui, JE Koehler, C Maguina, MJ Dolan, D Raoult Antimicrobial agents and chemotherapy 48 (6), 1921-1933, 2004 | 640 | 2004 |
| Dissemination of the mcr-1 colistin resistance gene AO Olaitan, S Chabou, L Okdah, S Morand, JM Rolain The Lancet infectious diseases 16 (2), 147, 2016 | 586 | 2016 |
| Chloroquine for the 2019 novel coronavirus SARS-CoV-2 P Colson, JM Rolain, D Raoult International journal of antimicrobial agents 55 (3), 105923, 2020 | 578 | 2020 |
| Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ... Travel medicine and infectious disease 35, 101738, 2020 | 575 | 2020 |
| ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome CA Devaux, JM Rolain, D Raoult Journal of Microbiology, Immunology and Infection 53 (3), 425-435, 2020 | 565 | 2020 |
| Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options M Kempf, JM Rolain International journal of antimicrobial agents 39 (2), 105-114, 2012 | 537 | 2012 |
| Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections A Sakr, F Brégeon, JL Mège, JM Rolain, O Blin Frontiers in microbiology 9, 2419, 2018 | 525 | 2018 |
| The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ... Clinical microbiology and infection 23 (1), 2-22, 2017 | 518 | 2017 |
| Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century JM Rolain, P Colson, D Raoult International journal of antimicrobial agents 30 (4), 297-308, 2007 | 489 | 2007 |
